Sol Kim1,2,3, Hyolim Kang1,2,3, Laura Skrip1,2,3

  • 1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London, UK.

PubMed
概括

尼帕病毒疫苗因疫情有限而面临有效性试验挑战. 替代性监管途径和国际合作对于尼帕的准备和疫苗开发至关重要.